Hwan Il Kim
Overview
Explore the profile of Hwan Il Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choi K, Kim H, Rhee C, Yoo K, Park Y, Kim Y, et al.
Int J Chron Obstruct Pulmon Dis
. 2024 Jul;
19:1661-1671.
PMID: 39050737
Background: COPD causes substantial economic burden on healthcare. Alternative treatment strategies for COPD can be associated with different costs dependent upon their relative safety and effectiveness. We compared costs and...
2.
Kim S, Kim T, Choi H, Shin T, Kim H, Jang S, et al.
Sci Rep
. 2024 May;
14(1):10462.
PMID: 38714885
Respiratory infections are common causes of acute exacerbation of chronic obstructive lung disease (AECOPD). We explored whether the pathogens causing AECOPD and clinical features changed from before to after the...
3.
Kim T, Kim S, Choi H, Shin T, Kim H, Jang S, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230708
The clinical outcomes of patients with lung cancer coexisting with chronic kidney disease (CKD) are reported to have been conflicting. There is insufficient evidence for treatment and prognosis of lung...
4.
Park J, Kim J, Park S, Hwang Y, Kim H, Jang S, et al.
Korean J Intern Med
. 2022 Aug;
37(5):989-1001.
PMID: 35989064
Background/aims: Pulmonary toxicities of coronavirus disease 2019 (COVID-19) vaccination are exceedingly rare. However, there are a few reported cases after mRNA vaccination, especially from Asian countries. The purpose of this...
5.
Choi H, Min C, Yoo D, Tan B, Kim J, Kim H, et al.
Front Pharmacol
. 2022 Jul;
13:888610.
PMID: 35847037
Proton-pump inhibitors (PPIs) block acid secretion from gastric parietal cells; however, recent studies have reported that PPIs have antioxidant and anti-inflammatory properties in various cells. Newer PPIs are stronger inhibitors...
6.
Park J, Jang S, Lee C, Kim T, Chung S, Lee Y, et al.
Tuberc Respir Dis (Seoul)
. 2022 Jan;
85(2):155-164.
PMID: 35045686
Background: The remarkable efficacy of osimertinib in non‒small cell lung cancer (NSCLC) with acquired T790M mutation has been widely documented in clinical trials and real-world practice. However, some patients show...
7.
Kim Y, Kim H, Park J, Hong J, Kim J, Min K, et al.
Korean J Intern Med
. 2021 Aug;
37(1):119-126.
PMID: 34412177
Background/aims: Hypoxemia in chronic obstructive pulmonary disease (COPD) leads to reduced ability to exercise, decreased quality of life, and, eventually, increased mortality. Home oxygen therapy in patients with severe COPD...
8.
Park J, Kim H, Kim J, Park S, Hwang Y, Jang S, et al.
Korean J Intern Med
. 2021 Aug;
36(5):1157-1168.
PMID: 34399570
Background/aims: Studies on the effectiveness of public health measures to prevent respiratory virus transmission in real-world settings are lacking. We investigated the effectiveness of universal mask use and adherence to...
9.
Park J, Kim J, Lee I, Kim H, Park S, Hwang Y, et al.
Thorax
. 2021 Aug;
77(1):102-104.
PMID: 34362838
No abstract available.
10.
Kim T, Choi H, Shin T, Ko Y, Park Y, Kim H, et al.
J Thorac Dis
. 2021 May;
13(4):2288-2299.
PMID: 34012579
Background: We would evaluate the epidemiology, clinical aspects, and prognostic factors of patients of all ages admitted with human corona virus (HCoV). Methods: This study was retrospectively performed at five...